NorthRock Partners »

Aldeyra Therapeutics shares owned by NorthRock Partners

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by NorthRock Partners from 13F filings

Historical chart of NorthRock Partners investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by NorthRock Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by NorthRock Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $42k 12k 3.51

More positions owned by NorthRock Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Apple (AAPL)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Spdr Ser Tr S&p 400 Mdcp Val (MDYV)
Spdr Ser Tr S&P 400 MDCP GRW (MDYG)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
Spdr Ser Tr S&P 600 SMCP GRW (SLYG)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Mondelez Intl Cl A (MDLZ)
Target Corporation (TGT)
Ishares Tr Msci Eafe Etf (EFA)
Amazon (AMZN)

View all positions for NorthRock Partners

Top funds holding Aldeyra Therapeutics

Perceptive Advisors
Knoll Capital Management
Vanguard Group
Kennedy Capital Management
Dimensional Fund Advisors
Damian Sousa
Millennium Management
Thomas Stevens, CFA"
Bank of America Corporation
Two Sigma Advisers
Wells Fargo & Company
Deutsche Bank Aktiengesellschaft
D. E. Shaw & Co
Palo Alto Investors
Two Sigma Investments

View all funds holding Aldeyra Therapeutics